<DOC>
	<DOCNO>NCT00033748</DOCNO>
	<brief_summary>RATIONALE : Vaccines may make body build immune response kill tumor cell . PURPOSE : Phase II trial study effectiveness vaccine therapy treat patient colorectal cancer spread liver .</brief_summary>
	<brief_title>Vaccine Therapy Treating Patients With Colorectal Cancer Metastatic Liver</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine 2-year recurrence-free survival patient minimal metastatic colorectal cancer hepatic resection treat adjuvant monoclonal antibody 3H1 anti-idiotype vaccine monoclonal antibody 11D10 anti-idiotype vaccine . Secondary - Determine toxicity regimen patient . OUTLINE : This multicenter study . Beginning 6-12 week curative hepatic resection , patient receive monoclonal antibody 3H1 anti-idiotype vaccine monoclonal antibody 11D10 anti-idiotype vaccine intracutaneously separate site day 1 , 15 , 29 , 45 , subcutaneously monthly 4 month . PROJECTED ACCRUAL : A total 63 patient accrue study within 9 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin Idiotypes</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm hepatic colorectal metastasis Must undergone complete resection hepatic colorectal metastasis tumorfree margin ( curative resection ) least 6 , 10 , week prior study entry No evaluable measurable disease hepatic resection , document intraoperative palpation image study include intraoperative ultrasound , CT scan , MRI No hereditary nonpolyposis colon cancer type B No CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : CTC 02 Life expectancy : Not specify Hematopoietic : WBC least 4,000/mm^3 Platelet count least 150,000/mm^3 Hepatic : Bilirubin great 2 mg/dL AST great 2 time upper limit normal ( ULN ) Renal : Creatinine great 1.5 time ULN Gastrointestinal : No celiac disease No familial polyposis No Gardner 's syndrome No PeutzJeghers syndrome Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No seizure disorder require continuous medication No history clinically significant hypersensitivity reaction , include know hypersensitivity rodent proteins No malignancy within past 5 year except adequately treat carcinoma situ cervix nonmelanoma skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : No prior murine antibody ( e.g. , oncoscint scan ) No prior monoclonal antibody 3H1 antiidiotype vaccine monoclonal antibody 11D10 antiidiotype vaccine Chemotherapy : No concurrent chemotherapy Endocrine therapy : No concurrent hormonal therapy except steroid adrenal failure hormone nondiseaserelated condition ( e.g. , insulin diabetes ) Radiotherapy : Not specify Surgery : See Disease Characteristics Other : Prior treatment primary lesion hepatic metastasis allow No concurrent immunomodulatory therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>liver metastasis</keyword>
</DOC>